Pneumococcal and influenza vaccination coverage and impact on COVID-19 infection severity in patients with inflammatory rheumatic diseases: A French National Healthcare Database analysis.

Date publication

juillet 2025

Journal

Vaccine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr SAULEAU Erik-André

Tous les auteurs :
Auroux M, Fabacher T, Sauleau E, Arnaud L, Coury F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40602345

Résumé

It has been suggested that vaccinations could induce a trained immunity able to decrease COVID-19 severity. Our primary aim was to evaluate the COVID-19 severity among patients with inflammatory rheumatic diseases (IRD) vaccinated against pneumococcus and influenza compared to those not vaccinated. A secondary objective was also to determine vaccination coverage within real-life population of IRD patients in France.

Mots clés

COVID-19, Inflammatory rheumatic disease, Influenza vaccination, Pneumococcal vaccination, Trained immunity

Référence

Vaccine. 2025 07 1;61:127439